Manke Isaac 4

What Happened

Isaac Manke, a director of Q32 Bio Inc. (QTTB), exercised stock options on 2026-06-30 to acquire 53,521 common shares at an exercise price of $2.80 per share, for a total cash outlay of $149,859. The filing also shows the related option instrument reported as disposed/converted at $0, which reflects the termination/conversion of the derivative upon exercise. This is an acquisition (exercise of options), not a public sale of the underlying shares.

Key Details

• Transaction date: 2026-06-30
• Acquisition: 53,521 shares acquired at $2.80 per share — total $149,859 (Transaction code M = option exercise)
• Derivative/option reported disposed: 53,521 @ $0.00 (reflects conversion/termination of the option)
• Footnote: F1 — "The shares underlying this option are fully vested and exercisable."
• Shares owned after the transaction: not specified in the filing excerpt provided
• Filing date: 2026-07-02 — filed within the normal reporting window (no late filing indicated)

Context

An option exercise means the insider paid the stated exercise price to convert vested options into common shares. The paired $0.00 disposition entry is standard accounting for the canceled/converted option instrument and does not mean a cash sale of shares. The filing does not report an immediate sale of the acquired shares, so this transaction represents an insider acquisition rather than a liquidation.